518 related articles for article (PubMed ID: 19406210)
1. Genomic and proteomic biomarkers for cancer: a multitude of opportunities.
Tainsky MA
Biochim Biophys Acta; 2009 Dec; 1796(2):176-93. PubMed ID: 19406210
[TBL] [Abstract][Full Text] [Related]
2. Proteomic Approaches for Biomarker Panels in Cancer.
Tanase C; Albulescu R; Neagu M
J Immunoassay Immunochem; 2016; 37(1):1-15. PubMed ID: 26565430
[TBL] [Abstract][Full Text] [Related]
3. Proteomics of cancer of hormone-dependent tissues.
Tyson DR; Ornstein DK
Adv Exp Med Biol; 2008; 630():133-47. PubMed ID: 18637489
[TBL] [Abstract][Full Text] [Related]
4. Clinical Perspective on Proteomic and Glycomic Biomarkers for Diagnosis, Prognosis, and Prediction of Pancreatic Cancer.
Hanna-Sawires RG; Schiphuis JH; Wuhrer M; Vasen HFA; van Leerdam ME; Bonsing BA; Mesker WE; van der Burgt YEM; Tollenaar RAEM
Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33800786
[TBL] [Abstract][Full Text] [Related]
5. The footprints of cancer development: Cancer biomarkers.
Ullah MF; Aatif M
Cancer Treat Rev; 2009 May; 35(3):193-200. PubMed ID: 19062197
[TBL] [Abstract][Full Text] [Related]
6. Progress and prospects for the discovery of biomarkers for gastric cancer: a focus on proteomics.
Mohri Y; Toiyama Y; Kusunoki M
Expert Rev Proteomics; 2016 Dec; 13(12):1131-1139. PubMed ID: 27744719
[TBL] [Abstract][Full Text] [Related]
7. Towards identification of true cancer biomarkers.
Diamandis EP
BMC Med; 2014 Sep; 12():156. PubMed ID: 25220599
[TBL] [Abstract][Full Text] [Related]
8. A proteomic signature of ovarian cancer tumor fluid identified by highthroughput and verified by targeted proteomics.
Poersch A; Grassi ML; Carvalho VP; Lanfredi GP; Palma CS; Greene LJ; de Sousa CB; Carrara HHA; Candido Dos Reis FJ; Faça VM
J Proteomics; 2016 Aug; 145():226-236. PubMed ID: 27222041
[TBL] [Abstract][Full Text] [Related]
9. Inconvenient truth: cancer biomarker development by using proteomics.
Kondo T
Biochim Biophys Acta; 2014 May; 1844(5):861-5. PubMed ID: 23896458
[TBL] [Abstract][Full Text] [Related]
10. Breast cancer proteomics: a review for clinicians.
Galvão ER; Martins LM; Ibiapina JO; Andrade HM; Monte SJ
J Cancer Res Clin Oncol; 2011 Jun; 137(6):915-25. PubMed ID: 21465318
[TBL] [Abstract][Full Text] [Related]
11. Cancer Proteomics and the Elusive Diagnostic Biomarkers.
Bradshaw RA; Hondermarck H; Rodriguez H
Proteomics; 2019 Nov; 19(21-22):e1800445. PubMed ID: 31172665
[TBL] [Abstract][Full Text] [Related]
12. Analytical validation considerations of multiplex mass-spectrometry-based proteomic platforms for measuring protein biomarkers.
Boja ES; Fehniger TE; Baker MS; Marko-Varga G; Rodriguez H
J Proteome Res; 2014 Dec; 13(12):5325-32. PubMed ID: 25171765
[TBL] [Abstract][Full Text] [Related]
13. ADAM Metalloprotease-Released Cancer Biomarkers.
Herrlich P; Herrlich A
Trends Cancer; 2017 Jul; 3(7):482-490. PubMed ID: 28718403
[TBL] [Abstract][Full Text] [Related]
14. SELDI proteinchip MS: a platform for biomarker discovery and cancer diagnosis.
Wright GL
Expert Rev Mol Diagn; 2002 Nov; 2(6):549-63. PubMed ID: 12465452
[TBL] [Abstract][Full Text] [Related]
15. Development of biomarkers of genitourinary cancer using mass spectrometry-based clinical proteomics.
Chen YT; Tsai CH; Chen CL; Yu JS; Chang YH
J Food Drug Anal; 2019 Apr; 27(2):387-403. PubMed ID: 30987711
[TBL] [Abstract][Full Text] [Related]
16. Discovery and Validation of Clinical Biomarkers of Cancer: A Review Combining Metabolomics and Proteomics.
Srivastava A; Creek DJ
Proteomics; 2019 May; 19(10):e1700448. PubMed ID: 30353665
[TBL] [Abstract][Full Text] [Related]
17. Emerging blood-based biomarkers for detection of gastric cancer.
Kalniņa Z; Meistere I; Kikuste I; Tolmanis I; Zayakin P; Linē A
World J Gastroenterol; 2015 Nov; 21(41):11636-53. PubMed ID: 26556992
[TBL] [Abstract][Full Text] [Related]
18. Proteomics of endometrial cancer diagnosis, treatment, and prognosis.
Mittal P; Klingler-Hoffmann M; Arentz G; Zhang C; Kaur G; Oehler MK; Hoffmann P
Proteomics Clin Appl; 2016 Mar; 10(3):217-29. PubMed ID: 26541900
[TBL] [Abstract][Full Text] [Related]
19. Proteomics biomarkers for solid tumors: Current status and future prospects.
Belczacka I; Latosinska A; Metzger J; Marx D; Vlahou A; Mischak H; Frantzi M
Mass Spectrom Rev; 2019 Jan; 38(1):49-78. PubMed ID: 29889308
[TBL] [Abstract][Full Text] [Related]
20. Proteomic contributions to personalized cancer care.
Koomen JM; Haura EB; Bepler G; Sutphen R; Remily-Wood ER; Benson K; Hussein M; Hazlehurst LA; Yeatman TJ; Hildreth LT; Sellers TA; Jacobsen PB; Fenstermacher DA; Dalton WS
Mol Cell Proteomics; 2008 Oct; 7(10):1780-94. PubMed ID: 18664563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
